Trial Profile

The effects of Nebivolol/HCTZ on Central Arterial Pressure, a randomised double-blind cross-over trial.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 27 Jul 2013

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Nebivolol (Primary) ; Hydrochlorothiazide; Metoprolol
Indications Essential hypertension
Focus Therapeutic Use
Acronyms NeMeCAP
Sponsors Menarini Benelux

Most Recent Events

17 Jun 2013 Primary endpoint 'Central-systolic-blood-pressure' has not been met.
17 Jun 2013 Primary endpoint 'Blood-pressure' has not been met.
17 Jun 2013 Primary endpoint 'Augmentation-index' has not been met.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com